Novacyt S.A.
NVYTF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$41.41M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $41.41 Million |
|---|---|
| Enterprise Value | $42.74 Million |
| Earnings per Share | $-0.33 |
| Beta | 1.11 |
| Outstanding Shares | 71,742,654 |
Return
| Return on Equity | -180.28% |
|---|---|
| Return on Assets | -89.59% |
| Return on Invested Capital | -47.70% |
Valuation & Multiples
| P/E Ratio | -0.81 |
|---|---|
| PEG | -0.99 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.16 |
| Enterprise Value to EBIT | -2.86 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.55 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
April 29, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Novacyt S.A.
216 employees
CEO: Lyn Dafydd Rees
Founded in 2006 and headquartered in Vélizy-Villacoublay, France, Novacyt S.A. and its subsidiaries are actively involved in the full lifecycle of diagnostic products, encompassing development, manufacturing, custom design, and global co...